Erratum: Efficacy and safety of tofacitinib following inadequate response to conventional synthetic or biologic diseasemodifying antirheumatic drugs

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Correction
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446002/
https://www.ncbi.nlm.nih.gov/pubmed/28213386
http://dx.doi.org/10.1136/annrheumdis-2014-207178corr1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5446002/
https://www.ncbi.nlm.nih.gov/pubmed/28213386
http://dx.doi.org/10.1136/annrheumdis-2014-207178corr1

Ejemplares similares